Shorts losing control as $SGMO stock confirm golden cross 50/200

Updated
Following on strong momentum after Novartis deal, Sangamo Therapeutics with strong open that looks set to breakout the stock from a long sustained downtrend
Trade active
Stay long, sgmo never breached below critical 9.4 support in my chart from august
Beyond Technical AnalysisbiotechgenetherapyMoving AveragesTrend Analysiszincfinger

Also on:

Disclaimer